country

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Conversion of atrial fibrillation with antazoline hydrochloride (Arithmin)

Angiology. 1970 Jan;21(1):11-7. doi: 10.1177/000331977002100104.

D A Gehring , J G Kehler

PMID: 5415197 DOI: 10.1177/000331977002100104

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-B1067

Antazoline hydrochloride

99.60%, Histamine Receptor Inhibitor

target: Histamine Receptor; HBV

Research Areas: Neurological Disease; Endocrinology
HY-B1067A

Antazoline

99.70%, H1 Receptor Antagonist

target: Histamine Receptor

Research Areas: Neurological Disease; Endocrinology
HY-B1067B

Antazoline phosphate

H1 Receptor Antagonist

target: Histamine Receptor

Research Areas: Neurological Disease; Endocrinology
HY-B1067R

Antazoline hydrochloride (Standard)

Histamine Receptor Inhibitor

target: Reference Standards; Histamine Receptor; HBV

Research Areas: Neurological Disease; Endocrinology
HY-B1067BR

Antazoline phosphate (Standard)

H1 Receptor Antagonist

target: Reference Standards; Histamine Receptor

Research Areas: Neurological Disease; Endocrinology
HY-B1067AR

Antazoline (Standard)

H1 Receptor Antagonist

target: Reference Standards; Histamine Receptor

Research Areas: Neurological Disease; Endocrinology